Table 5.
Summary of qRT‐PCR Results
| Overexpressed genes | Downregulated gene | ||||
|---|---|---|---|---|---|
| EIF51 | ECGF1 | ANPEP | PP1201 | GKN1 | |
| All cases | 9/31 (29)a | 15/31 (48) | 14/31 (45) | 15/31 (48) | 30/31 (97) |
| Gender | |||||
| Male | 4/19 (21) | 8/19 (42) | 10/19 (53) | 14/19 (74) | 19/19 (100) |
| Female | 2/4 (50) | 3/4 (75) | 1/4 (25) | 1/4 (25) | 4/4 (100 |
| 3/8 (38) | 4/8 (50) | 3/8 (38) | 0/8 (0) | 7/8 (88) | |
| Site | |||||
| GEJ | 4/10 (40) | 7/16 (44) | 7/16 (44) | 10/16 (63) | 16/16 (100) |
| ESO | 3/10 (30) | 4/10 (40) | 4/10 (40) | 5/10 (50) | 10/10 (100) |
| NA | 2/5 (40) | 4/5 (80) | 3/5 (60) | 0/5 (0) | 4/5 (80) |
| Stage | |||||
| T1–T2 | 2/8 (25) | 3/8 (37) | 5/8 (62) | 6/8 (75) | 8/8 (100) |
| T3–T4 | 5/14 (36) | 7/14 (50) | 5/14 (36) | 8/14 (57) | 14/14 (100) |
| NA | 3/9 (33) | 5/9 (55) | 4/9 (44) | 1/9 (11) | 8/9 (89) |
| Grade | |||||
| WD‐MD | 3/10 (30) | 5/10 (50) | 5/10 (50) | 8/10 (80) | 10/10 (100) |
| PD | 2/9 (22) | 4/9 (44) | 5/9 (56) | 6/9 (67) | 9/9 (100) |
| NA | 4/12 (33) | 6/12 (50) | 4/12 (33) | 1/12 (8) | 11/12 (92) |
| Node | |||||
| N0 | 2/8 (25) | 2/8 (25) | 5/8 (63) | 6/8 (75) | 8/8 (100) |
| N1–N2 | 4/13 (31) | 7/13 (54) | 4/13 (31) | 7/13 (54) | 13/13 (100) |
| N3–N4 | 0/0 (0) | 0/0 (0) | 0/0 (0) | 0/0 (0) | 0/0 (0) |
| NA | 3/10 (30) | 6/10 (60) | 5/10 (50) | 2/10 (20) | 9/10 (90) |
a
Values in parentheses are percentages. NA, information not available; GEJ, gastroesophageal junction; ESO, esophageal; WD, well‐differentiated; MD, moderately‐differentiated; PD, poorly differentiated. We did not observe statistical significance with any of the correlates due to small sample size.